Global partnerships

Global innovation, backed by dedicated local investment

For every partner, we build a long-term regulatory, commercial and operational platform designed specifically for Iraq's market dynamics.

01
AstraZenecaPartnership established 1996
02
ServierPartnership established 2012
03
MSDPartnership established 2017
04
PfizerPartnership established 2018
05
AbbViePartnership established 2024

Our promise

What an Al Hayat partner can expect

01

Strategic partnership

Long-term partnerships backed by investment in people, infrastructure and capabilities for sustainable growth.

02

Compliance & governance

Iraqi regulatory expertise aligned with international standards for transparency, integrity and continuity.

03

Therapeutic expertise

Experience across oncology, respiratory, cardiovascular, endocrinology, vaccines and specialty care.

04

Market leadership

Three decades navigating public tenders, regulatory pathways and private-market dynamics in Iraq.

05

Dedicated investment

Dedicated teams, market-access initiatives, compliance systems and commercial infrastructure.

Partnership meeting at Al Hayat

Market entry

One path from strategy to execution

Our partnerships team works as one unit with regulatory, market access, sales, supply chain, quality and pharmacovigilance functions to turn strategy into sustainable presence.

Market and regulatory pathway assessment
Dedicated team and commercial platform
Ongoing performance, governance and compliance reporting